HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis

Abdel-Fatah, T.M.A., McArdle, S.E. ORCID: 0000-0001-6929-9782, Agarwal, D., Moseley, P.M., Green, A.R., Ball, G.R. ORCID: 0000-0001-5828-7129, Pockley, A.G. ORCID: 0000-0001-9593-6431, Ellis, I.O., Rees, R.C. and Chan, S.Y.T., 2015. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research. ISSN 1078-0432

Full text not available from this repository.
Item Type: Journal article
Publication Title: Clinical Cancer Research
Creators: Abdel-Fatah, T.M.A., McArdle, S.E., Agarwal, D., Moseley, P.M., Green, A.R., Ball, G.R., Pockley, A.G., Ellis, I.O., Rees, R.C. and Chan, S.Y.T.
Publisher: American Association for Cancer Research
Place of Publication: Philadelphia, PA, USA
Date: 2015
ISSN: 1078-0432
Identifiers:
NumberType
10.1158/1078-0432.CCR-15-0610DOI
Divisions: Schools > School of Science and Technology
Depositing User: EPrints Services
Date Added: 09 Oct 2015 09:47
Last Modified: 09 Jun 2017 13:10
URI: http://irep.ntu.ac.uk/id/eprint/2754

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year